Cyvex Receives Patent Notice for Memory Enhancer Ingredient
Cognisetin is a fisetin-based ingredient that has been shown to stimulate the signaling pathways that enhance long-term memory.
1/13/2011 --- Cyvex Nutrition has confirmed that its branded cognitive health ingredient Cognisetin, a fisetin-based ingredient introduced last summer in an exclusive license agreement with the Salk Institute for Biological Studies, was issued a Notice of Allowance (NOA) for a key patent specific to methods of using flavonoids to enhance memory by the US Patent and Trademark Office (USPTO).
The USPTO issued the NOA to indicate the application, entitled "Methods of Using Flavonoids to Enhance Memory," is genuinely novel. The patent describes fisetin as a neuroprotector capable of generating neuron cells in the presence of damage, promoting antioxidant synthesis, and reducing overactive brain- and spinal cord-specific immune defenses that contribute to age-related decline and/or conditions.
"The resulting patent illustrates Cyvex's commitment to the nutraceutical industry by providing evidence-based ingredients with proven scientific support. This patent validates Cognisetin's status as a genuinely novel ingredient with a clinically-backed cognitive health benefit,” said Matt Phillips, president and CEO of Cyvex Nutrition.
Cognisetin is a fisetin-based ingredient that has been shown to stimulate the signaling pathways that enhance long-term memory. Fisetin, a naturally occurring flavonol found in fruits and vegetables including strawberries, serves as a powerful antioxidant by maintaining mitochondrial function during oxidative stress, and has been shown to efficiently cross the blood brain barrier, thus providing great potential in neuroprotection.
